Filing Details

Accession Number:
0001144204-10-000147
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-04 12:00:00
Reporting Period:
2009-12-30
Filing Date:
2010-01-04
Accepted Time:
2010-01-04 16:16:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1318641 Cleveland Biolabs Inc CBLI Services-Commercial Physical & Biological Research (8731) 200077155
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1369806 Michael Fonstein 73 High Street
Buffalo NY 14203
Ceo, President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2009-12-30 751 $3.55 1,286,400 No 4 S Direct
Common Stock Disposition 2009-12-30 200 $3.60 1,286,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Options (Right to Buy) $8.36 2007-04-06 2017-04-05 37,500 37,500 Direct
Common Stock Employee Stock Options (Right to Buy) $4.00 2008-02-04 2018-02-03 137,250 174,750 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-04-05 37,500 37,500 Direct
2018-02-03 137,250 174,750 Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.3% of the reporting person's 1,549,600 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 3.9% of the reporting person's shares held prior to adoption of the plan.